Abstract
Purpose
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatocarcinogenesis is correlated with a series of gene expression alteration. Here, we investigated LAMA4 gene expression in hepatocellular carcinoma on both mRNA and protein levels, expecting to explore the relationship between expressional abundances of LAMA4 and the clinical characteristics of HCC specimens.
Method
Total RNA was extracted from 48 cases of surgically resected HCC specimens and their corresponding peripheral tumor-free liver tissues. After the optimal reverse transcription polymerase chain reaction condition was established, the mRNA levels of LAMA4 in tumor and peripheral tumor-free tissues were examined semi-quantitatively. The relationship between expression levels of LAMA4 and clinical pathological characteristics was further analyzed by two-tailed t-test and χ2 test. We also used anti-LAMA4 antibody to detect the in vivo distribution of LAMA4 protein by tissue immunofluorescence staining in HCC specimens and their peripheral tumor-free tissues.
Results
The expression level of LAMA4 in 48 cases of human hepatocellular carcinoma tissues was significantly higher than that in their corresponding peripheral tumor-free tissues (0.37 ± 0.25 vs. 0.18 ± 0.12, P < 0.01). LAMA4 gene was up-regulated in 30 (62.50%) cases of HCC, down regulated in 4 (8.33%) cases, and showed no significant changes in 14 (29.17%) cases. Analysis of relationship between LAMA4 gene expression abundances and clinical characteristics by χ2 test showed that up-regulation of LAMA4 was strongly correlated with tumor invasion (79.31%), incomplete or no envelope (75.00%) and tumor bolt (86.67%). Additionally, tissue immunofluorescence staining against LAMA4 protein detected strong signal only in HCC tissues but not their corresponding peripheral tumor-free liver tissues. To our attention, LAMA4 protein showed specific in vivo distribution along the basement membrane of tumor blood vessels, bringing insights into its potential role in tumor angiogenesis.
Conclusions
LAMA4 is specifically up-regulated on both mRNA and protein levels in hepatocelluar carcinoma. The strong correlation between high expression abundances of LAMA4 with tumor invasion and metastasis, as well as, LAMA4 specific in vivo distribution in tumor basement membrane, indicated LAMA4’s potential role in hepatocarcinogenesis and tumor progression. Therefore, we hypothesize that LAMA4 is probably a novel supplementary marker for HCC diagnosis, and might be a molecular target in the future cancer therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Meneguzzi G, Paulsson M, Sanes J, et al (1994) A new nomenclature for the laminins. Matrix Biol 14(3):209–211
Chen J, Yu L, Li D, Gao Q, Wang JS, Huang XH, Bi G, Zhao SY (2003) Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians. Gene 302:103–113
DeHahn KC, Gonzales M, Gonzalez AM, Hopkinson SB, Chandel NS, Brunelle JK, Jones JC (2004) The alpha4 laminin subunit regulates endothelial cell survival. Exp Cell Res 294(1):281–289
Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E (1992) Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 84:1638–1641
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 350:427–428
Huang XH, Sun LH, Lu DD, Sun Y, Ma LJ, Zhang XR, Huang J, Yu L (2003) Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World J Gastroenterol 9(4):692–695
Huang XH, Lu DD, Ji GQ, Sun Y, Ma LJ, Chen Z, Zhang LS, Huang J, Yu L (2004) Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China. Virus Res 99:63–68
Iivanainen A, Sainio K, Sariola H, Tryggvason K (1995) Primary structure and expression of a novel human laminin alpha 4 chain. FEBS Lett 365(2–3):183–188
Jackson PE, Groopman JD (1999) Aflatoxin and liver cancer. Baillieres Best Pract Res Clin Gastroenterol 13:545–555
Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, Wang JB, Wu Y, Kensler TW, Vogelstein B, Groopman JD (2001) Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res 61:33–35
Jan F Talts, Takako S, Nicolai M, Walter G, Karlheinz M, Richard M, Rupert T (2000) Structure and functional analysis of the recombinant G domain of the laminin a4 chain and its proteolytic processing in tissues. J Biol Chem 275(45):35192–35199
Jiang JM, Yu L, Huang XH, Chen XS, Gao J, Zhang YZ, Tang LS, Zhao SY (2001) Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in HCC tissues from 68 Chinese patients. Gene 281:103–113
Khazenzon NM, Ljubimov AV, Lakhter AJ, Fujita M, Fujiwara H, Sekiguchi K, Sorokin LM, Petajaniemi N, Virtanen I, Black KL, Ljubimova JY (2003) Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Mol Cancer Ther 2(10):985–994
Lian J, Dai X, Li X, He F (2006) Identification of an active site on the laminin alpha4 chain globular domain that binds to alphavbeta3 integrin and promotes angiogenesis. Biochem Biophys Res Commun 347(1):248–253
Ljubimova JY, Fujita M, Khazenzon NM, Ljubimov AV, Black KL (2006) Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. Front Biosci 11:81–88
Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM (1997) p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57:3471–3477
Nagato S, Nakagawa K, Harada H, Kohno S, Fujiwara H, Sekiguchi K, Ohue S, Iwata S, Ohnishi T (2005) Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo. Int J Cancer 117(1):41–50
Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 60:6519–6525
Richards A, Al-Imara L, Carter NP, Lloyd JC, Leversha MA, Pope FM (1994) Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain. Genomics 22(1):237–239
Richards A, Al-Imara L, Pope FM (1996) The complete cDNA sequence of laminin alpha 4 and its relationship to the other human laminin alpha chains. Eur J Biochem 238(3):813–821
Richards A, Luccarini C, Pope FM (1997) The structural organisation of LAMA4, the gene encoding laminin alpha4. Eur J Biochem 248(1):15–23
Acknowledgments
We thank Professor Takako Sasaki (Shriners Hospital for Children, Research Center, Portlands) for providing rabbit antisera against mouse laminin alpha4 fragments alpha4LG1-3 and alpha4LG4-5. This work was supported by Science Foundation of Innovation Research Group , National Natural Science Foundation of China (No. 30024001).
Author information
Authors and Affiliations
Corresponding author
Additional information
Xinghua Huang and Guoqing Ji contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Huang, X., Ji, G., Wu, Y. et al. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J Cancer Res Clin Oncol 134, 705–714 (2008). https://doi.org/10.1007/s00432-007-0342-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-007-0342-6